Holen Sie sich die Stockscreener-App
4.00
6.67%
0.25
Schlusskurs vom Vortag:
$3.75
Offen:
$3.93
24-Stunden-Volumen:
558.47K
Relative Volume:
0.65
Marktkapitalisierung:
$123.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.24M
KGV:
-4.7738
EPS:
-0.8379
Netto-Cashflow:
$-22.47M
1W Leistung:
+14.29%
1M Leistung:
+5.54%
6M Leistung:
+53.26%
1J Leistung:
-33.99%
1-Tages-Spanne:
$3.76
$4.09
1-Wochen-Bereich:
$3.28
$4.09
52-Wochen-Spanne:
$1.14
$7.11
Skye Bioscience Inc Stock (SKYE) Company Profile
Firmenname
Skye Bioscience Inc
Sektor
Branche
Telefon
(858) 410-0266
Adresse
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Vergleichen Sie SKYE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.78 | 1.86B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.48 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.37 | 103.78M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3441 | 797.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.15 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-28 | Eingeleitet | William Blair | Outperform |
| 2024-09-30 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-04-12 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten
What indicators show strength in Skye Bioscience Inc.July 2025 Analyst Calls & Weekly High Momentum Picks - Newser
Should you hold or exit Skye Bioscience Inc. nowJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Can Skye Bioscience Inc. deliver consistent dividendsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - خودرو بانک
How volatile is Skye Bioscience Inc. stockPortfolio Gains Report & AI Powered Market Entry Strategies - خودرو بانک
Rate Hike: Will Skye Bioscience Inc. outperform the market in YEAREarnings Summary Report & Consistent Profit Trading Strategies - خودرو بانک
Custom watchlist performance reports with Skye Bioscience Inc.2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Can swing trading help recover from Skye Bioscience Inc. lossesJuly 2025 Setups & Verified Technical Trade Signals - Newser
Is Skye Bioscience Inc. stock poised for growth2025 Major Catalysts & Safe Capital Growth Plans - Newser
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data - Benzinga
Is Skye Bioscience Inc. building a consolidation base2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Can Skye Bioscience Inc. hit a new high this month2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Chart based analysis of Skye Bioscience Inc. trends2025 Sector Review & Consistent Profit Trading Strategies - Newser
Is Skye Bioscience Inc. vulnerable to short sellersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - خودرو بانک
How hedge fund analytics apply to Skye Bioscience Inc. stockJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Skye Bioscience Presents Virtual KOL Event Transcript: Interpreting CBeyond Phase IIa Top Line Results - AInvest
Is Skye Bioscience Inc. stock entering bullish territoryMarket Risk Report & Pattern Based Trade Signal System - Newser
Skye Bioscience: A High-Conviction Play in Obesity Innovation Amid Rising R&D Costs - AInvest
Skye Bioscience Reports Promising Results for Nimacimab in Obesity Studies - AInvest
Skye Bioscience reports promising obesity treatment data in mice - Investing.com
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Treatment Weight Maintenance in DIO Model - GlobeNewswire
Will Skye Bioscience Inc. benefit from macro trendsPortfolio Growth Summary & Long-Term Growth Portfolio Plans - Newser
Volume spikes in Skye Bioscience Inc. stock – what they meanWeekly Profit Analysis & High Yield Stock Recommendations - Newser
What MACD signals say about Skye Bioscience Inc.Weekly Trade Review & Expert Verified Stock Movement Alerts - Newser
Is Skye Bioscience Inc. showing signs of accumulationWeekly Profit Recap & Daily Volume Surge Signals - Newser
Multi asset correlation models including Skye Bioscience Inc.July 2025 PreEarnings & Real-Time Price Movement Reports - Newser
Skye Bioscience Inc. stock chart pattern explainedJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Aug Catalysts: Is Skye Bioscience Inc.’s growth already priced inQuarterly Market Summary & Daily Chart Pattern Signals - خودرو بانک
Sentiment analysis tools applied to Skye Bioscience Inc.July 2025 Short Interest & Safe Capital Growth Stock Tips - Newser
Is Skye Bioscience Inc. stock bottoming out2025 Macro Impact & Risk Adjusted Buy/Sell Alerts - Newser
Analyzing drawdowns of Skye Bioscience Inc. with statistical toolsJuly 2025 Decliners & Low Drawdown Investment Strategies - Newser
Real time alert setup for Skye Bioscience Inc. performanceTrade Volume Report & High Return Stock Watch Alerts - Newser
What’s the beta of Skye Bioscience Inc. stockJuly 2025 Trade Ideas & AI Based Buy/Sell Signal Reports - خودرو بانک
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study - GlobeNewswire
Sector ETF performance correlation with Skye Bioscience Inc.Quarterly Profit Report & Real-Time Buy Signal Notifications - Newser
Will Skye Bioscience Inc. benefit from seasonalityJuly 2025 Chart Watch & Weekly Chart Analysis and Guides - خودرو بانک
Using AI based signals to follow Skye Bioscience Inc.July 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
What does recent volatility data suggest for Skye Bioscience Inc.July 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
Can Skye Bioscience Inc. maintain its current growth rateJuly 2025 Review & Risk Managed Trade Strategies - خودرو بانک
Is Skye Bioscience Inc.’s growth already priced in2025 Price Momentum & Detailed Earnings Play Strategies - خودرو بانک
What’s the profit margin of Skye Bioscience Inc.Market Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Published on: 2025-09-02 07:19:02 - Newser
Novel Obesity Drug Combined with Wegovy: Skye Completes Phase 2a Trial with 52-Week Extension Study - Stock Titan
How do insiders feel about Skye Bioscience Inc.July 2025 Reactions & Smart Allocation Stock Tips - خودرو بانک
Candlestick signals on Skye Bioscience Inc. stock todayWeekly Profit Recap & Real-Time Stock Price Movement Reports - Newser
Finanzdaten der Skye Bioscience Inc-Aktie (SKYE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):